-
Strategies for a discontinuous future.












Wednesday, August 18, 2004
 


Antibiotic resistance is quietly lurking as a potential disaster of black death proportions. High rates of bacterial mutation, general disinterest and improper drug use by the public, in combination with prohibitively high development and testing costs for pharma companies is leading us down a dangerous path.

So what's this mean? Well aside from a complete overhaul of the FDA (or relevant regulatory agency) drug approval policy for antibiotics or a concerted international effort to provide incentive for novel antibiotic or alternative drug therapy development (both of which seem unlikely any time in the near future), we're all screwed.

Seriously though, this type of trend will likely lead to some developing markets for products such as this. Crazy yes, but likely an indication of things to come. More promising developments (involving legitimate science) are mentioned here. My bet is on the bacteriaphages (good time to read up on some old Russian science).

-- dhd // 5:17 PM //


Comments:

Speaking of Russian science...don't forget colloidal silver. It was one of THE standard treatments before the advent of sulfa drugs and antibiotics--and was used by Florence Nightengale in the Crimean War. I have personally used it to great effect to cure...nasty infections I won't horrify you with.
// Shaula Evans // 6:15 PM
 

I've heard colloidal silver works, although the FDA isn't very happy with it. Mind you, I wouldn't want to turn in to the fourth member of the blue man group, if you know what I mean.
// dhd // 7:00 PM
 
Post a Comment
search



new


input

due diligence
ventureblog
a vc
techblurbs
tj's weblog
venture chronicles
terranova
the big picture
gigaom
venchar
bill burnham
babak nivi
n-c thoughts
paidcontent
techdirt
slashdot
london gsb
mefi
boingboing
blort
hardwax
betalounge

ing
morgan
chicago fed
dallas fed
ny fed
imf
world bank
nouriel roubini

portfolio
contact

mail.
uhaque (dot) mba2003 (at) london (dot) edu

skype.
umair.haque

atom feed

technorati profile

blog archives